RK-4 injection

DRUG2 trials

Sponsors

Neurodawn Pharmaceutical Co., Ltd., Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd

Conditions

Acute Ischemic StrokeAcute Large Hemispheric InfarctionAcute Large Hemispheric Infarction StrokeRK-4Transcranial Bone Marrow Injection

Phase 1

RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction

Not yet recruitingNCT07166380

Neurodawn Pharmaceutical Co., Ltd.Acute Ischemic Stroke, Acute Large Hemispheric Infarction, RK-4 +1

Start: 2025-09-20End: 2026-05-19Target: 18Updated: 2025-09-30

Phase 2

RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction

Not yet recruitingNCT07203521

Fuzhou Neurodawn Rongkang Pharmaceutical Co., LtdAcute Ischemic Stroke, Acute Large Hemispheric Infarction Stroke, RK-4 +1

Start: 2025-11-01End: 2026-10-07Target: 194Updated: 2025-10-02